161 related articles for article (PubMed ID: 38325364)
1. MUC1-EGFR crosstalk with IL-6 by activating NF-κB and MAPK pathways to regulate the stemness and paclitaxel-resistance of lung adenocarcinoma.
Xu H; Du Z; Li Z; Liu X; Li X; Zhang X; Ma J
Ann Med; 2024 Dec; 56(1):2313671. PubMed ID: 38325364
[TBL] [Abstract][Full Text] [Related]
2. Paclitaxel alleviated sepsis-induced acute lung injury by activating MUC1 and suppressing TLR-4/NF-κB pathway.
Wang YM; Ji R; Chen WW; Huang SW; Zheng YJ; Yang ZT; Qu HP; Chen H; Mao EQ; Chen Y; Chen EZ
Drug Des Devel Ther; 2019; 13():3391-3404. PubMed ID: 31576113
[TBL] [Abstract][Full Text] [Related]
3. Downregulated Mucin 1 alleviates paclitaxel resistance in non‑small cell lung cancer cells.
Xu H; Gao H; Li H; Li D; Yuan W; Zhang L; Cheng P; Su X; Li Z; Wang G; Zhang T
Mol Med Rep; 2020 Oct; 22(4):2966-2972. PubMed ID: 32945387
[TBL] [Abstract][Full Text] [Related]
4. Upregulation of MUC1 by its novel activator 14-3-3ζ promotes tumor invasion and indicates poor prognosis in lung adenocarcinoma.
Xue M; Tao W
Oncol Rep; 2017 Nov; 38(5):2637-2646. PubMed ID: 28901525
[TBL] [Abstract][Full Text] [Related]
5. Long Non-Coding RNA CRNDE Is Involved in Resistance to EGFR Tyrosine Kinase Inhibitor in EGFR-Mutant Lung Cancer via eIF4A3/MUC1/EGFR Signaling.
Takahashi S; Noro R; Seike M; Zeng C; Matsumoto M; Yoshikawa A; Nakamichi S; Sugano T; Hirao M; Matsuda K; Hamada M; Gemma A
Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33924522
[TBL] [Abstract][Full Text] [Related]
6. Modulation of macrophage polarization and lung cancer cell stemness by MUC1 and development of a related small-molecule inhibitor pterostilbene.
Huang WC; Chan ML; Chen MJ; Tsai TH; Chen YJ
Oncotarget; 2016 Jun; 7(26):39363-39375. PubMed ID: 27276704
[TBL] [Abstract][Full Text] [Related]
7. Triptolide reverses the Taxol resistance of lung adenocarcinoma by inhibiting the NF-κB signaling pathway and the expression of NF-κB-regulated drug-resistant genes.
Jiang N; Dong XP; Zhang SL; You QY; Jiang XT; Zhao XG
Mol Med Rep; 2016 Jan; 13(1):153-9. PubMed ID: 26531258
[TBL] [Abstract][Full Text] [Related]
8. Membrane-tethered MUC1 mucin is phosphorylated by epidermal growth factor receptor in airway epithelial cells and associates with TLR5 to inhibit recruitment of MyD88.
Kato K; Lillehoj EP; Park YS; Umehara T; Hoffman NE; Madesh M; Kim KC
J Immunol; 2012 Feb; 188(4):2014-22. PubMed ID: 22250084
[TBL] [Abstract][Full Text] [Related]
9. Microarray expression profile of long non-coding RNAs in paclitaxel-resistant human lung adenocarcinoma cells.
Tian X; Zhang H; Zhang B; Zhao J; Li T; Zhao Y
Oncol Rep; 2017 Jul; 38(1):293-300. PubMed ID: 28586074
[TBL] [Abstract][Full Text] [Related]
10. Rsf-1 Influences the Sensitivity of Non-Small Cell Lung Cancer to Paclitaxel by Regulating NF-κB Pathway and Its Downstream Proteins.
Chen X; Sun X; Guan J; Gai J; Xing J; Fu L; Liu S; Shen F; Chen K; Li W; Han L; Li Q
Cell Physiol Biochem; 2017; 44(6):2322-2336. PubMed ID: 29258089
[TBL] [Abstract][Full Text] [Related]
11.
Pu J; Shen J; Zhong Z; Yanling M; Gao J
Artif Cells Nanomed Biotechnol; 2020 Dec; 48(1):639-647. PubMed ID: 32064933
[TBL] [Abstract][Full Text] [Related]
12. LINC02535/miR-30a-5p/GALNT3 axis contributes to lung adenocarcinoma progression via the NF- κ B signaling pathway.
Li Y; Zhao J; Zhang W; Wang A; Jiao M; Cai X; Zhu J; Liu Z; Huang JA
Cell Cycle; 2022 Dec; 21(23):2455-2470. PubMed ID: 35852407
[TBL] [Abstract][Full Text] [Related]
13. Circular RNA CDR1-AS contributes to pemetrexed and cisplatin chemoresistance through EGFR/PI3K signaling pathway in lung adenocarcinoma.
Mao Y; Xu R
Biomed Pharmacother; 2020 Mar; 123():109771. PubMed ID: 31881486
[TBL] [Abstract][Full Text] [Related]
14. IL-1β-Mediated Up-Regulation of WT1D via miR-144-3p and Their Synergistic Effect with NF-κB/COX-2/HIF-1α Pathway on Cell Proliferation in LUAD.
Wu C; Li X; Zhang D; Xu B; Hu W; Zheng X; Zhu D; Zhou Q; Jiang J; Wu C
Cell Physiol Biochem; 2018; 48(6):2493-2502. PubMed ID: 30121641
[TBL] [Abstract][Full Text] [Related]
15. A real-world study and network pharmacology analysis of EGFR-TKIs combined with ZLJT to delay drug resistance in advanced lung adenocarcinoma.
Han X; Liang L; He C; Ren Q; Su J; Cao L; Zheng J
BMC Complement Med Ther; 2023 Nov; 23(1):422. PubMed ID: 37990309
[TBL] [Abstract][Full Text] [Related]
16. MUC1 attenuates neutrophilic airway inflammation in asthma by reducing NLRP3 inflammasome-mediated pyroptosis through the inhibition of the TLR4/MyD88/NF-κB pathway.
Liu L; Zhou L; Wang L; Mao Z; Zheng P; Zhang F; Zhang H; Liu H
Respir Res; 2023 Oct; 24(1):255. PubMed ID: 37880668
[TBL] [Abstract][Full Text] [Related]
17. An intrinsic purine metabolite AICAR blocks lung tumour growth by targeting oncoprotein mucin 1.
Aftab F; Rodriguez-Fuguet A; Silva L; Kobayashi IS; Sun J; Politi K; Levantini E; Zhang W; Kobayashi SS; Zhang WC
Br J Cancer; 2023 May; 128(9):1647-1664. PubMed ID: 36810913
[TBL] [Abstract][Full Text] [Related]
18. Targeting the MUC1-C oncoprotein inhibits self-renewal capacity of breast cancer cells.
Alam M; Rajabi H; Ahmad R; Jin C; Kufe D
Oncotarget; 2014 May; 5(9):2622-34. PubMed ID: 24770886
[TBL] [Abstract][Full Text] [Related]
19. FZKA reverses gefitinib resistance by regulating EZH2/Snail/EGFR signaling pathway in lung adenocarcinoma.
Tang Q; Xu M; Long S; Yu Y; Ma C; Wang R; Li J; Wang X; Fang F; Han L; Wu W; Wang S
J Ethnopharmacol; 2024 Jan; 318(Pt A):116646. PubMed ID: 37269912
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-22 enhances chemoresistance of lung adenocarcinoma cells to paclitaxel.
Huang Z; Gao Y; Hou D
Hum Cell; 2020 Jul; 33(3):850-858. PubMed ID: 32452013
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
